TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
4Pharma AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
2,833
|
1,337
|
1,163 |
Financial expenses |
0
|
9
|
7 |
Earnings before taxes |
427
|
16
|
40 |
EBITDA |
420
|
26
|
46 |
Total assets |
1,383
|
591
|
552 |
Current assets |
1,380
|
584
|
548 |
Current liabilities |
540
|
300
|
272 |
Equity capital |
843
|
290
|
279 |
- share capital |
9
|
10
![]() |
10 |
Employees (average) |
22
|
10
|
6 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
61.0%
|
49.1%
|
50.5% |
Turnover per employee |
129
|
134
|
194 |
Profit as a percentage of turnover |
15.1%
|
1.2%
|
3.4% |
Return on assets (ROA) |
30.9%
|
4.2%
|
8.5% |
Current ratio |
255.6%
|
194.7%
|
201.5% |
Return on equity (ROE) |
50.7%
|
5.5%
|
14.3% |
Change turnover |
1,604
|
196
|
590 |
Change turnover % |
131%
|
17%
|
103% |
Chg. No. of employees |
12
|
4
|
3 |
Chg. No. of employees % |
120%
|
67%
|
100% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.